Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters

[1]  Jun Liu,et al.  Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score , 2022, Journal of Cancer Research and Clinical Oncology.

[2]  Fang Yuan,et al.  Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study , 2022, European Radiology.

[3]  J. Byun,et al.  Liver Imaging Reporting and Data System categories: Long‐term imaging outcomes in a prospective surveillance cohort , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[4]  X. Gan,et al.  Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients. , 2022, Hepatobiliary & pancreatic diseases international : HBPD INT.

[5]  P. Yang,et al.  Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching , 2022, BMC Surgery.

[6]  Jeong Min Lee,et al.  Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[7]  T. Pawlik,et al.  Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis , 2022, Annals of Surgical Oncology.

[8]  Wenliang Fan,et al.  The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma , 2021, Abdominal Radiology.

[9]  Y. Choi,et al.  Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma , 2021, World Journal of Surgery.

[10]  Wei Wei,et al.  Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma , 2021, JAMA network open.

[11]  S. Kubo,et al.  The Prognostic Impact of Tumor Differentiation on Recurrence and Survival after Resection of Hepatocellular Carcinoma Is Dependent on Tumor Size , 2021, Liver Cancer.

[12]  Zhiduan Xu,et al.  The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma , 2021, International journal of general medicine.

[13]  Jeong Ah Hwang,et al.  Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI , 2021, Korean journal of radiology.

[14]  W. Pei,et al.  Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasion. , 2021, European journal of radiology.

[15]  Xinhua Jiang,et al.  Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection , 2021, Abdominal Radiology.

[16]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[17]  C. Sirlin,et al.  Liver Imaging Reporting and Data System , 2020, Advances in Clinical Radiology.

[18]  Weiping Zhou,et al.  Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection , 2020, Cancer medicine.

[19]  Kathryn J Fowler,et al.  The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection , 2019, Front. Oncol..

[20]  Haiping Zhang,et al.  Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy. , 2019, Academic radiology.

[21]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[22]  C. Sirlin,et al.  LI-RADS Version 2018 Ancillary Features at MRI. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  Kathryn J Fowler,et al.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. , 2018, Radiology.

[24]  Sang Joon Park,et al.  Hepatocellular carcinoma: preoperative gadoxetic acid–enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis , 2018, Abdominal Radiology.

[25]  W. Cong,et al.  Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[26]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[27]  Jeong Ah Hwang,et al.  Pre-operative ADC predicts early recurrence of HCC after curative resection , 2018, European Radiology.

[28]  Jiayin Yang,et al.  The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis , 2018, BMC Cancer.

[29]  Jiapeng Zhou,et al.  Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma , 2018, Journal of hepatocellular carcinoma.

[30]  Ming‐Lung Yu,et al.  Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection , 2017, Journal of the Chinese Medical Association : JCMA.

[31]  W. Cong,et al.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update , 2016, World journal of gastroenterology.

[32]  Kui Wang,et al.  Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. , 2016, JAMA surgery.

[33]  Yong Eun Chung,et al.  Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. , 2015, Radiology.

[34]  L. Pang,et al.  Low Pretherapeutic Serum Albumin as a Risk Factor for Poor Outcome in Esophageal Squamous Cell Carcinomas , 2015, Nutrition and cancer.

[35]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Masakazu Yamamoto,et al.  A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma , 2011, Journal of hepato-biliary-pancreatic sciences.

[37]  D. Gupta,et al.  Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature , 2010, Nutrition journal.

[38]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.